The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
A systematic study of microdosing psychedelics
Open accessPublished version of a preprint
Abstract
The phenomenon of 'microdosing', that is, regular ingestion of very small quantities of psychedelic substances, has seen a rapid explosion of popularity in recent years. Individuals who microdose report minimal acute effects from these substances yet claim a range of long-term general health and wellbeing benefits. There have been no published empirical studies of microdosing and the current legal and bureaucratic climate makes direct empirical investigation of the effects of psychedelics difficult. In Study One we conducted a systematic, observational investigation of individuals who microdose. We tracked the experiences of 98 microdosing participants, who provided daily ratings of psychological functioning over a six week period. 63 of these additionally completed a battery of psychometric measures tapping mood, attention, wellbeing, mystical experiences, personality, creativity, and sense of agency, at baseline and at completion of the study. Analyses of daily ratings revealed a general increase in reported psychological functioning across all measures on dosing days but limited evidence of residual effects on following days. Analyses of pre and post study measures revealed reductions in reported levels of depression and stress; lower levels of distractibility; increased absorption; and increased neuroticism. To better understand these findings, in Study Two we investigated pre-existing beliefs and expectations about the effects of microdosing in a sample of 263 naïve and experienced microdosers, so as to gauge expectancy bias. All participants believed that microdosing would have large and wide-ranging benefits in contrast to the limited outcomes reported by actual microdosers. Notably, the effects believed most likely to change were unrelated to the observed pattern of reported outcomes. The current results suggest that dose controlled empirical research on the impacts of microdosing on mental health and attentional capabilities are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“therapeutic benefit of low doses of psychedelics remains to be demonstrated in a well-controlled clinical study”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [249]
The cited source says what the claim attributes to it.
In the citing paper
“the data on human psychedelic microdosing are equivocal”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [249]
The cited source says what the claim attributes to it.
In the citing paper
“but other studies did not find this effect in a general population sample (12) and a general sample without individuals diagnosed with a mood, anxiety, substance use, psychotic or dissociative disorder (13).”
From Trait mindfulness and personality characteristics in a microdosing ADHD sample: a naturalistic prospective survey study (2023) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Though one prospective (survey) study investigating adults (excluding individuals with mood, anxiety, substance use, psychotic or dissociative disorders) did not find a change in mindfulness scores after MD (13)”
From Trait mindfulness and personality characteristics in a microdosing ADHD sample: a naturalistic prospective survey study (2023) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“though other studies investigating healthy individuals did not find this effect (13, 29).”
From Trait mindfulness and personality characteristics in a microdosing ADHD sample: a naturalistic prospective survey study (2023) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“but was increased in a sample consisting of adults without mood, anxiety, substance use, and psychotic or dissociative disorders (13).”
From Trait mindfulness and personality characteristics in a microdosing ADHD sample: a naturalistic prospective survey study (2023) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“The discrepancy between the findings by Polito and Stevenson (13) and the current study could potentially be explained by different sample characteristics as they excluded individuals with certain mental disorders, such as mood and anxiety disorders.”
From Trait mindfulness and personality characteristics in a microdosing ADHD sample: a naturalistic prospective survey study (2023) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“The finding that mindfulness was enhanced in MD individuals is in line with previous studies reporting this association (6, 11), but in contrast to one previous prospective MD study that did not find any changes in mindfulness after 6 weeks of MD (13).”
From Trait mindfulness and personality characteristics in a microdosing ADHD sample: a naturalistic prospective survey study (2023) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The benefits of being present: Mindfulness and its role in psychological well-being
Brown, K. W., & Ryan, R. M. (2003) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.84.4.822 · Cited by 13,448
A general and simple method for obtaining R 2 from generalized linear mixed‐effects models
Nakagawa, S., & Schielzeth, H. (2013) · Methods in Ecology and Evolution · doi:10.1111/j.2041-210x.2012.00261.x · Cited by 10,356
(1995) · Cited by 6,909
nlme: Linear and Nonlinear Mixed Effects Models
Pinheiro, J., R Core Team, & Bates, D. (1999) · doi:10.32614/cran.package.nlme · Cited by 6,867
Wandering minds: the default network and stimulus-independent thought
Mason, M. F., Norton, M. I., Van Horn, J. D., Wegner, D. M., Grafton, S. T., & Macrae, C. N. (2007) · Science · doi:10.1126/science.1131295 · Cited by 2,792
A wandering mind is an unhappy mind
Killingsworth, M. A., & Gilbert, D. T. (2010) · Science · doi:10.1126/science.1192439 · Cited by 2,575
Goodman and Gilman's The Pharmacological Basis of Therapeutics
Hastings, R. C. (1996) · JAMA · doi:10.1001/jama.1996.03540120077042 · Cited by 2,375
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201
Tellegen, A., & Atkinson, G. (1974) · Journal of Abnormal Psychology · doi:10.1037/h0036681 · Cited by 2,196
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Research works printed but not linked: 4
- S. Grof, 1972, Varieties of transpersonal experiences: Observations from LSD psychotherapy, The Journal of Transpersonal Psychology, 4, 45
- R. Glatter, 2015, LSD Microdosing: The New Job Enhancer In Silicon Valley And Beyond?, Forbes
- Camps R. Cosmetic Consciousness: Cross-sectional exploration of the microdosing community and empirical examination of anecdotal benefits [Internet]. 2017. Available: https://www.researchgate.net/publication/319442972_Cosmetic_Consciousness_Cross-sectional_exploration_of_the_microdosing_community_and_empirical_examination_of_anecdotal_benefits
- D. Nichols, 2016, Psychedelics, Pharmacol Rev, 68, 264, 10.1124/pr.115.011478 · DOI · Paper page
Cited by
Sorted by citations
Items 201–235 of 235
Tendencias y experiencias del consumo de microdosis de hongos psilocibios en Colombia
Suárez, C., Quintero, S., & Gil, J. M. C. (2023) · Cultura y Droga · doi:10.17151/culdr.2023.28.35.7 · Cited by 1
“La dietilamida de ácido lisérgico (LSD) y la psilocibina, el componente psicoactivo de los hongos psilocibios, han sido las sustancias más comúnmente usadas en la práctica y discutidas en la naciente investigación sobre microdosificación (Polito y Stevenson, 2019).”
BackgroundInfluentialInvestigación sobre microdosificación con hongos psilocibios: un artículo de reflexión
Duque, L. (2023) · Cultura y Droga · doi:10.17151/culdr.2023.28.35.3
“…et al., 2020; Rosenbaum et al. , 2020; Webb et al. , 2019), reducciones en el estrés (Polito & Stevenson, 2019) , depresión (Cameron et al. , 2020; Polito & Stevenson, 2019; Webb et al. , 2019) y ansiedad (Cameron et al. , 2020; Kaertner et al. , 2021; Lea et al. , 2020; Polito & Stevenson, 2019).”
BackgroundPetrovitch, D., Mitchell, S. M., Allen, J. V., & Littlefield, A. K. (2024) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/adnpg
Psilocybin and other Psychedelics
Kaye, A. P., Kelmendi, B., Rivera, M. N., & Pittenger, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00178-0
Afonso, J. R., Nakamura, F. Y., Baptista, I., Rendeiro-Pinho, G., Brito, J., & Figueiredo, P. (2024) · Strength and conditioning journal · doi:10.1519/ssc.0000000000000856
Microdosing Psychedelics as a Promising New Pharmacotherapeutic
Kuypers, K. P. C. (2024) · Springer eBooks · doi:10.1007/978-3-031-61992-2_26
Totomanova, I., Haijen, E. C. H. M., Hurks, P. P. M., Ramaekers, J. G., & Kuypers, K. P. C. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.03.002
Drugs of Abuse and Cardiotoxicity
Cheng, Y.-Y., Badheka, A., Mohamad, T. N., & Alfonso, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00213-8
Sattler, S., Wood, S. C., Petersen, M. A., Seiffert, F., & Mehlkop, G. (2025) · Scientific Reports · doi:10.1038/s41598-025-03873-0
Nasini, S., Barzon, B., Tidei, S., Casile, A., Cambiaghi, M., Martin, S. D., Mattarei, A., Battelli, L., Bolognini, N., Marzoli, S. B., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5348341
Los riesgos de consumir estimulantes para rendir más en el trabajo
Guzmán, J. L. (2024) · doi:10.64628/aao.yv7g43gkw
“It Fueled the Fire to Who I Am Now”: Exploring Motivations for Microdosing Psychedelics
Beaton, B. (2025) · Journal of Drug Issues · doi:10.1177/00220426251395178
Murphy, R. J., Wardlaw, M., Smith, T., Noorani, T. N., Evans, W., Reynolds, L., Menkes, D. B., Sumner, R. L., & Muthukumaraswamy, S. D. (2025) · Journal of Humanistic Psychology · doi:10.1177/00221678251382624
Bansal, M., Miller, E., Sumner, R. L., Ponton, R., Muthukumaraswamy, S., & Svirskis, D. M. (2025) · Journal of Chromatographic Science · doi:10.1093/chromsci/bmaf054
Donegan, C. J., Daldegan‐Bueno, D., Sumner, R. L., Forsyth, A., Evans, W., Hoeh, N. R., Sundram, F., Menkes, D. B., Muthukumaraswamy, S. D., & Reynolds, L. (2025) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253251396253
Wells, A., Muthukumaraswamy, A. P. S., Morunga, E., Evans, W., Cavadino, A., Bansal, M., Lawrence, N. J., Ashley, A., Hoeh, N. R., Sundram, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25210532
Murphy, R. J., Godfrey, K., Shaw, A. D., Muthukumaraswamy, S., & Sumner, R. L. (2024) · Figshare · doi:10.6084/m9.figshare.25150540
Wells, A., Muthukumaraswamy, A. P. S., Morunga, E., Evans, W., Cavadino, A., Bansal, M., Lawrence, N. J., Ashley, A., Hoeh, N. R., Sundram, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25210812
Donegan, C. J., Daldegan‐Bueno, D., Sumner, R. L., Menkes, D., Evans, W. J., Hoeh, N. R., Sundram, F., Reynolds, L., Ponton, R., Cavadino, A., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24257434
Daldegan‐Bueno, D., Donegan, C. J., Forsyth, A., Sumner, R. L., Murphy, R. J., Menkes, D. B., Evans, W. J., Hoeh, N. R., Sundram, F., Reynolds, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26942922
Daldegan‐Bueno, D., Donegan, C. J., Forsyth, A., Sumner, R. L., Murphy, R. J., Menkes, D. B., Evans, W. J., Hoeh, N. R., Sundram, F., Reynolds, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26827416
Murphy, R. J., Sumner, R. L., Evans, W. J., Menkes, D., Lambrecht, I., Ponton, R., Sundram, F., Hoeh, N. R., Ram, S., Reynolds, L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14478492
Daldegan‐Bueno, D., Donegan, C. J., Forsyth, A., Sumner, R. L., Murphy, R. J., Menkes, D. B., Evans, W. J., Hoeh, N. R., Sundram, F., Reynolds, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26827380
Banzato, M., Colognesi, M., Lucatello, L., Comai, S., Pasut, G., Capolongo, F., Orian, L., Biasutto, L., Signor, A., Gabbia, D., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01797
Scheggi, S., Braccagni, G., Branca, C., & Bortolato, M. (2026) · Aggression and Violent Behavior · doi:10.1016/j.avb.2026.102139
The Online Attention to Spiritual Health Research: An Altmetric Analysis
Saberi, M. K., Mokhtari, H., Ahangari, S. A. H., Ouchi, A., & Shourcheh, B. (2026) · THE NEW ARMENIAN MEDICAL JOURNAL · doi:10.56936/18290825-2026.20v.2-108
Inserra, A., VanderZwaag, J., Campanale, A., Murray, C. J., & Szabo, A. J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27340-7.00008-5
Classic psychedelics and personality: An updated systematic review
Vicentini, A. B., de Paula, C. C., Reis, J. A. S., Bouso, J. C., Hallak, J. E. C., & SANTOS, R. G. D. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261449386
“…et al., 2019; Haijen et al., 2023; Hübner et al., 2021; Johnstad, 2021; Kiraga et al., 2021, 2022; Lebedev et al., 2023; Mason et al., 2020; Netzband et al., 2020; Nour et al., 2017; Perkins et al., 2022; Polito et al., 2019; Ross and Neill, 2023; Sjöström et al., 2024; Weiss et al., 2021a, 2021b).”
InfluentialOlejníková, L., Kútna, V., Mazochová, K., Šíchová, K., Danda, H., Lhotková, E., Uttl, L., Brejtr, V., Syrová, K., Mazoch, V., et al. (2026) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2026.174231
Participatory Drug Market Surveillance: Implications for Nursing Science and Practice
Speight, C., Smirnova, O., & Ryan, D. H. (2026) · International Journal of Addiction Nursing · doi:10.1097/jan.0000000000000709
Evaluating psilocybin for the management of depression: a literature review
Sinclair, R. (2026) · British Journal of Mental Health Nursing · doi:10.12968/bjmh.2025.0020
The subtle science: a systematic review of psilocybin magic mushroom and truffle microdosing
Page, J., Moore, A., Hawkins, B. E., Lyons, E., & Lorenzo, E. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1866881
“The scienti fi c literature on microdosing is characterized by substantial variability in study design, dosing regimens, psilocybin preparations, and outcome measures, as well as a reliance on self-report and observational methodologies (13, 15 – 17 , 23).”
Bonilla, J. N. V. (2026) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.70063
“For example, Polito and Stevenson (2019) found that prior beliefs about the positive effects of microdosing did not fully align with the outcomes observed.”
Psychedelic-Induced Changes in Personality Traits: A Systematic Review
Bartkiewicz, P. A., Baran, W. P., & Lachowska, E. M. (2026) · Roczniki Psychologiczne · doi:10.18290/rpsych2025.0017
“…al., 2025; Griffiths et al., 2018; Kiraga et al., 2022, Lebedev et al., 2016; Madsen et al., 2020; Mendes Rocha et al., 2021; Murphy et al., 2023; Polito & Stevenson, 2019; Schmid & Liechti, 2017; Timmermann et al., 2024) included exclusively healthy participants with no current or past…”
InfluentialCannabis and Psilocybin Co-use: Associations with Stress and Well-being
Obrochta, A. N., & Cservenka, A. (2026) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-026-01744-x
Metadata
- Authors
- Polito, V., & Stevenson, R. J.
- Affiliations
- Macquarie University (AU)
- Corresponding author
- Polito, Vince
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-02-06
- Volume
- 14
- Issue
- 2
- Pages
- e0211023
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6364961
- OpenAlex
- W2895986834
- Cited by
- 235
- References
- 87
- Citations by year
- 2026: 19 · 2025: 31 · 2024: 36 · 2023: 30 · 2022: 32 · 2021: 39 · 2020: 29 · 2019: 18
- FWCI
- 34.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
- Social Sciences › Psychology › Social Psychology › Psychological Well-being and Life Satisfaction
- Keywords
- microdosing, psychedelics, psychological functioning, mood, depression, stress, attention, distractibility, absorption, neuroticism, creativity, mystical experience, sense of agency, expectancy bias, mental health, well-being
- MeSH terms
- Patient Reported Outcome Measures, Adult, Attention, Culture, Dose-Response Relationship, Drug, Female, Hallucinogens, Humans, Male, Mental Health, Middle Aged, Personality, Psychometrics, Empirical Research, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
